Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PLCbeta4 blockade is a potential approach for treating uveal melanoma

Jan. 4, 2022

Novel allosteric inhibitor of tumor-promoting PPI between AIMP2-DX2 and HSP70

Jan. 4, 2022

Roche identifies new ENPP2 inhibitors

Jan. 4, 2022

Chinese researchers synthesize new SOS1 inhibitors

Jan. 4, 2022

Medshine Discovery discloses EZH2 inhibitors

Jan. 4, 2022

YAP1 promotes salivary gland regeneration after injury

Jan. 4, 2022

Siglec-15 promotes osteosarcoma tumor progression

Jan. 3, 2022

Novel halogenated phenoxychalcones described with activity in breast cancer cell lines

Jan. 3, 2022

Mission Therapeutics synthesizes USP30 inhibitors

Jan. 3, 2022

Betta Pharmaceuticals divulges new PTPN11 inhibitors

Jan. 3, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...